Cadmium in brown crab Cancer pagurus. Effects of location, season, cooking and multiple physiological factors and consequences for food safety

Brown crab Cancer pagurus is appreciated as seafood in several European countries. However, cadmium levels in crabs can be elevated and their consumption may pose a hazard for human health. To assess if cadmium poses a threat to food safety in Norway, crabs were sampled at two different locations along the Norwegian coast: one in the South of Norway and one in the North of Norway. Cadmium levels were determined in different tissues (claw meat, hepatopancreas and inner meat). To highlight specific risk factors for cadmium, the concentration of cadmium was related to different exogenous (location, cooking and season) and physiological (size, sex, moulting stage, gonad maturation stage, condition) factors. The results confirmed previous findings of much higher cadmium levels in brown crab sampled in the North of Norway compared to the South. Cooking of crabs further led to higher concentrations in claw meat. The effect of season on cadmium levels was different in the North and South and no clear patterns could be identified, probably due to a high inter-individual variation in cadmium levels. Size showed a correlation with the total amount of cadmium for crabs in the North indicating an accumulation of cadmium over time; together with a slower growth, this may lead to the higher cadmium levels, observed in the crabs from Northern Norway. The risk connected to cadmium exposure when consuming brown crab mainly depends on the consumption pattern, the parts of the crab consumed and the origin of the crab. Regardless of origin, the consumption of claw meat does not display a consumer health risk. However, the consumption of meals consisting of inner meat only and inner meat of brown crab from Northern Norway may pose a health risk.publishedVersio

Sugar and cocoa: sweet synergy or bitter antagonisms. Formulating cocoa and chocolate products for health: a narrative review

The potential health effects of cocoa flavanols are well described. Ranging from reducing risk of developing type 2 diabetes and cardiovascular disease at population levels, moderating disease risk factors including endothelial function and lipid metabolism in clinical trials and mechanistic studies in laboratory studies highlighting target tissues and pathways. However, translating these benefits into public health messages is problematic, due to the high energy and sugar content of many cocoa products, including chocolate. This review considered the role of sugar in cocoa products, what are its physiological effects on bioavailability and bioactivity? Considering, then how cocoa products can be reformulated to reduce sugar intake, and the likely effects on beneficial effects of cocoa flavanols and consumer preferences. Ultimately, although interesting physiological effects are seen with cocoa flavanols, their use as a disease‐modifying commodities may be limited the effect such products may have within an individual's and populations overall dietary patterns

Factors influencing risk assessments of brominated flame-retardants; evidence based on seafood from the North East Atlantic Ocean

Brominated flame-retardants (BFRs) such as polybrominated diphenyl ethers (PBDE) and hexabromocyclododecane (HBCD) are considered hazardous to human health. Due to their persistence, they are still present in the environment and in biota and seafood is major contributor of BFRs to human exposure. Here, we used data from >9700 samples of wild and farmed fish, fish feed and fish feed ingredients collected from the North Atlantic between 2006 and 2016 aiming to investigate factors influencing the risk assessments of BFRs. Due to most representative number of analyses, PBDEs were the main focus of investigation. Mean ∑PBDE in fillet samples ranged from below quantification in Atlantic cod fillet to 2.0 μg kg−1 in Atlantic halibut. The main congener contributing to the ∑PBDE in all species was BDE 47. Factors affecting the level of BFR in seafood were multifaceted, and the levels were within species mainly determined by fish age, geographical origin and time of sampling. BDE 47, 99, 153 and HBCD were selected for margin of exposure (MOE) evaluation. When other sources of BFR than seafood were excluded, our risk assessment showed low risk at the current dietary intake of seafood. However, the dietary intake of BDE 99 may be of concern for toddlers when all sources are considered. The choice of fish species, dietary studies, choice of statistics, as well as exposure from other sources than seafood, were all factors that influenced the final MOE of BFRs. We propose the use of regression on order statistics as a tool for risk assessment, to illustrate means and spreads in large surveillance datasets to avoid the issue of measurements below the limit of quantification. A harmonized, updated evaluation of the risk associated with exposure to BFRs from diet, air and dust is warranted, where the fish species most commonly consumed also is taken into consideration.publishedVersio

Results from the intercalibration of optical low light calibration sources 2011

Following the 38th Annual European Meeting on Atmospheric Studies by Optical Methods in Siuntio in Finland, an intercalibration workshop for optical low light calibration sources was held in Sodankylä, Finland. The main purpose of this workshop was to provide a comparable scale for absolute measurements of aurora and airglow. All sources brought to the intercalibration workshop were compared to the Fritz Peak reference source using the Lindau Calibration Photometer built by Wilhelm Barke and Hans Lauche in 1984. The results were compared to several earlier intercalibration workshops. It was found that most sources were fairly stable over time, with errors in the range of 5–25%. To further validate the results, two sources were also intercalibrated at UNIS, Longyearbyen, Svalbard. Preliminary analysis indicates agreement with the intercalibration in Sodankylä within about 15–25%.publishedVersio

Prospecting Secondary Raw Materials in the Urban Mine and mining wastes (ProSUM) Recommendations Report

This Report presents the recommendations arising from the ProSUM Project. It contains recommendations designed to continue to improve the knowledge base for secondary raw materials with the overarching objective of increasing recycling and supply of such materials. It specifically addresses data availability, data quality, data harmonisation, data structure and data presentation.The report contains a complete list of recommendations arising from the work undertaken in the project covering the ‘urban mine’ of electrical and electronic equipment, batteries and vehicles, their wastes, and mining wastes. It is the culmination of three years’ work which has resulted in:• The characterisation of products in terms of CRM content;• A comprehensive review and screening of all available data to characterise products;• An assessment of the factors affecting CRM content in products and the future trends for products;• A comprehensive review of existing and development of new methodologies for sampling and analysisof products;• An assessment of the current stocks of products held in households and business;• The quantification of flows of waste products not captured by national reporting on producer compliance;• A new model to quantify stocks and flows of products, their waste and material flows;• A comprehensive review and screening of all available data to characterise waste flows;• A comprehensive review of existing and development of new methodologies for sampling and analysisof wastes;• An evaluation of relevant product waste flows and mining wastes deposits;• Creation of the Urban Mine Platform (UMP) including a unified data model and code lists and meta datasystem;• Expansion of the Minerals Knowledge Data Platform (MKDP) for mining wastes;• And a new harmonised classification system to describe data in the urban mine

Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma

The Asp358Ala variant in the interleukin-6 receptor (IL-6R) gene has been implicated in asthma, autoimmune and cardiovascular disorders, but its role in other respiratory conditions such as chronic obstructive pulmonary disease (COPD) has not been investigated. The aims of this study were to evaluate whether there is an association between Asp358Ala and COPD or asthma risk, and to explore the role of the Asp358Ala variant in sIL-6R shedding from neutrophils and its pro-inflammatory effects in the lung. We undertook logistic regression using data from the UK Biobank and the ECLIPSE COPD cohort. Results were meta-analyzed with summary data from a further three COPD cohorts (7,519 total cases and 35,653 total controls), showing no association between Asp358Ala and COPD (OR = 1.02 [95% CI: 0.96, 1.07]). Data from the UK Biobank showed a positive association between the Asp358Ala variant and atopic asthma (OR = 1.07 [1.01, 1.13]). In a series of in vitro studies using blood samples from 37 participants, we found that shedding of sIL-6R from neutrophils was greater in carriers of the Asp358Ala minor allele than in non-carriers. Human pulmonary artery endothelial cells cultured with serum from homozygous carriers showed an increase in MCP-1 release in carriers of the minor allele, with the difference eliminated upon addition of tocilizumab. In conclusion, there is evidence that neutrophils may be an important source of sIL-6R in the lungs, and the Asp358Ala variant may have pro-inflammatory effects in lung cells. However, we were unable to identify evidence for an association between Asp358Ala and COPD.This work was supported by the UK Medical Research Council [MR/L003120/1 and MR/J00345X/1]; the British Heart Foundation [RG/13/13/30194]; the UK National Institute for Health Research Cambridge Biomedical Research Centre; and the Cambridge NIHR BRC Cell Phenotyping Hub. The Cardiovascular Epidemiology Unit at the University of Cambridge is supported by the UK Medical Research Council [G0800270]; the British Heart Foundation [SP/09/002]; and the UK National Institute for Health Research Cambridge Biomedical Research Centre. The ECLIPSE study is supported by GlaxoSmithKline [SCO104960]. The COPDGene study was supported by National Institutes of Health [R01 HL089897 and R01 HL089856]. The Norway GenKOLS study is supported by GlaxoSmithKline [RES11080]. The VA Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Center of the U.S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, MA. Funding to pay the Open Access publication charges for this article was provided by University of Cambridge block grants from the Research Councils UK and the Charity Open Access Fund